MAR 02, 2020 9:10 AM PST

Bluetooth-enabled skin patch monitors diabetics' glucose levels

WRITTEN BY: Tara Fernandez

A new wearable skin patch could completely transform the daily glucose tracking routines for diabetics. This innovation, developed by the UK-based company Nemaura Medical, transmits data on circulating glucose to a mobile app via Bluetooth every five minutes. This continuous glucose monitor (CGM), named sugarBEAT®, is both non-invasive and inexpensive, making it a considerable step-up from traditional CGM devices

At just one millimeter in thickness, the disposable sugarBEAT® skin patch is designed to be inconspicuous and comfortable for use during an individual’s waking hours. A closer look at the mechanics of the device reveals tiny electronic currents that draw interstitial fluid from tissues towards the surface of the skin. The amount of glucose present in this liquid is indicative of its concentration in the blood, with the device alerting the wearer to take the required measures to stabilize glucose levels as needed.

 

 

CEO of Nemaura, Faz Chowdhury, said: “We believe that most people with diabetes do not currently use any continuous glucose monitoring system due to the high costs and the invasiveness of current products. We believe that sugarBEAT® changes this paradigm and is the first non-invasive CGM to provide the [masses] an option for daily monitoring whenever they choose at an affordable price point.”

Recently, the biotech announced plans to conduct several studies in 2020 to demonstrate the feasibility of the device as an alternative or complementary method for managing diabetes.

Researchers predict a staggering 463 million people suffer from diabetes worldwide, with that number set to spike considerably in the next decade. Keeping an eye on glucose levels and adjusting them regularly with a reliable CGM system is a fundamental part of controlling the progression of diabetes, together with lifestyle changes and pharmaceutical interventions.

Optimistic of the device’s revolutionary potential, Chowdhury said, “We believe that sugarBEAT®'s flexibility empowers users with very powerful trend data at a lower cost compared to current CGM's, which we believe will encourage broad adoption of the system"

 

Sources: Streetwise Reports, Nemaura Medical

 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
AUG 06, 2020
Clinical & Molecular DX
Device Diagnoses Breast Cancer in 60 Minutes
AUG 06, 2020
Device Diagnoses Breast Cancer in 60 Minutes
Researchers have created a point-of-care device that can provide diagnostic results for breast cancer in under an hour. ...
AUG 17, 2020
Cancer
Are Cancer Exosomes a Good Source of Biomarkers?
AUG 17, 2020
Are Cancer Exosomes a Good Source of Biomarkers?
One of cancer’s most aggravating qualities is its ability to control the microenvironment around it. This control ...
AUG 16, 2020
Microbiology
Newly Discovered Gut Enzyme Could Function as Disease Biomarker
AUG 16, 2020
Newly Discovered Gut Enzyme Could Function as Disease Biomarker
Bacteria in the gut have a powerful influence on our health, in part because all of those microbes have genes of their o ...
SEP 25, 2020
Clinical & Molecular DX
Ray of Hope: Rare Cancer Biomarker Discovered
SEP 25, 2020
Ray of Hope: Rare Cancer Biomarker Discovered
Biliary tract cancer, or BTC, isn’t as talked about as breast or prostate cancers, probably because its incidence ...
OCT 01, 2020
Clinical & Molecular DX
Presenting the World's Smallest Ultrasound Detector
OCT 01, 2020
Presenting the World's Smallest Ultrasound Detector
It’s smaller than a human cell, but the diminutive size of the newly-developed ultrasound detector is by no means ...
NOV 03, 2020
Clinical & Molecular DX
"Hello? It's Me, the Coronavirus."
NOV 03, 2020
"Hello? It's Me, the Coronavirus."
Researchers at MIT have discovered an unlikely way of discerning those with COVID-19 from healthy individuals — si ...
Loading Comments...